Miguel Ángel Piris

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker

Ken H. Young, Lydia Sánchez, Alexandar Tzankov, 2016, Oncotarget.